Clinical Trial Update: A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

View source ↗

Summary

A pilot study is ongoing to monitor natural killer cells and circulating tumor cells in women previously treated for non-metastatic triple-negative breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Cynvenio Biosystems | Conditions: Triple Negative Breast Cancer, Natural Killer Cells | Status: UNKNOWN